Keyvan Rezaï
Hôpital René Huguenin(FR)Institut Curie(FR)
Publications by Year
Research Areas
Estrogen and related hormone effects, Inflammatory mediators and NSAID effects, Protein Degradation and Inhibitors, Advanced Breast Cancer Therapies, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study(2016)427 cited
- → Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study(2016)422 cited
- → Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network(2019)307 cited
- → Q fever: a biological weapon in your backyard(2003)302 cited
- → Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors(2018)274 cited
- → Surgical Management of Endocarditis: The Society of Thoracic Surgeons Clinical Practice Guideline(2011)200 cited